XML 91 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Equity (Tables)

12 Months Ended

Dec. 31, 2023

Equity

Schedule of total shares

​

​	​	​
Common shares issued and outstanding at December 31, 2020		180,460,565
Follow-on public offering, incl. Greenshoe	​	5,750,000
Share option exercises	​	910,163
Common shares issued and outstanding at December 31, 2021	​	187,120,728
Shares issued as part of the at-the-market offering program	​	6,908,493
Shares issued to former shareholders of Frame Pharmaceuticals	​	858,496
Shares issued for LTIP option exercises and RSU deliveries	​	109,374
Common shares issued and outstanding at December 31, 2022	​	194,997,091
Shares issued as part of the at-the-market offering program	​	1,748,218
Shares issued as part of the public offering	​	27,027,028
Shares issued for LTIP option exercises and RSU releases	​	216,338
Common shares issued and outstanding at December 31, 2023	​	223,988,675

X

- References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfClassesOfShareCapitalAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of classes of share capital. [Refer: Share capital [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration